Glaucoma drainage devices as a novel treatment option in the management of recurrent iris cysts

IntroductionEpithelial inclusion cysts of the iris are a rare complication following ocular surgery or trauma and typically exhibit a more aggressive course than other types of iris cysts. Their management remains challenging due to their tendency for rapid growth, which can lead to obscuration of the visual axis, elevated intraocular pressure, corneal decompensation, and secondary glaucoma or uveitis. Particularly in pediatric and young adult patients, the high proliferative capacity of epithelial cells increases the risk of recurrence. Current treatment modalities, including Nd:YAG laser cyst disruption, sclerosing agent irrigation, and complete surgical excision, are associated with high recurrence rates.MethodsIn this retrospective case series we describe two patients with a recurrent iris cyst resulting from a trauma in childhood, and successfully managed with glaucoma drainage devices (Baerveldt tube and PAUL tube) to provide continuous cyst fluid drainage.ResultsIn both cases, implantation of the drainage device effectively controlled the progression of the cyst and maintained its position outside the visual axis. The pediatric patient developed a scleral perforation at the surgical site one year postoperatively, following additional mechanical trauma from ocular rubbing; this complication was successfully managed with surgical repair, resulting in a favorable outcome. In the second case, the patient experienced a transient postoperative diplopia, which resolved spontaneously without further intervention.ConclusionThese cases illustrate the potentially promising role of glaucoma drainage devices as a new treatment strategy for recurrent iris cysts, particularly after multiple prior resections or when conventional therapies have failed.

Institutions

Publication Details

Journal
European Journal of Ophthalmology
Published
2026-05-19
DOI
https://doi.org/10.1177/11206721261453629
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Glaucoma drainage devices as a novel treatment option in the management of recurrent iris cysts

European Journal of Ophthalmology
Ocular Oncology and Treatments
article

Glaucoma drainage devices as a novel treatment option in the management of recurrent iris cysts

article en

Abstract

IntroductionEpithelial inclusion cysts of the iris are a rare complication following ocular surgery or trauma and typically exhibit a more aggressive course than other types of iris cysts. Their management remains challenging due to their tendency for rapid growth, which can lead to obscuration of the visual axis, elevated intraocular pressure, corneal decompensation, and secondary glaucoma or uveitis. Particularly in pediatric and young adult patients, the high proliferative capacity of epithelial cells increases the risk of recurrence. Current treatment modalities, including Nd:YAG laser cyst disruption, sclerosing agent irrigation, and complete surgical excision, are associated with high recurrence rates.MethodsIn this retrospective case series we describe two patients with a recurrent iris cyst resulting from a trauma in childhood, and successfully managed with glaucoma drainage devices (Baerveldt tube and PAUL tube) to provide continuous cyst fluid drainage.ResultsIn both cases, implantation of the drainage device effectively controlled the progression of the cyst and maintained its position outside the visual axis. The pediatric patient developed a scleral perforation at the surgical site one year postoperatively, following additional mechanical trauma from ocular rubbing; this complication was successfully managed with surgical repair, resulting in a favorable outcome. In the second case, the patient experienced a transient postoperative diplopia, which resolved spontaneously without further intervention.ConclusionThese cases illustrate the potentially promising role of glaucoma drainage devices as a new treatment strategy for recurrent iris cysts, particularly after multiple prior resections or when conventional therapies have failed.

European Journal of Ophthalmology
KU Leuven (BE)
Good health and well-being
Openalex Percentile: Top 4%
Ocular Oncology and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.